The constant Research and Development is a principle of Vetanco DNA and the reason why a major part of its budget is allocated to that purpose. For Vetanco, being on the cutting-edge is rewarding because […] See more

Due to the rising interest in Biotech Vac. Technology, Sherry Layton, Chief Scientific Officer of Vetanco USA, was invited to develop the subject: “Reducing The Use Of Antimicrobials Through Innovative Universal Subunit Vaccine Platform Design.” […] See more

What follows is a general outlook of the reality that pig farming in the United States has been facing, especially in the slaughter area. In the video, our colleague, Jeffrey W. Hall, Director of Research […] See more

Bioinnovo, the public-private company (INTA–Vetanco) made its first contribution to the macro collaborative project conducted by a scientific committee that brings together more than twenty male and female researchers from different institutions. Those institutions are […] See more

Sherry Layton, Vetanco’s Chief Scientific Officer, gave a presentation on Increasing Feed Efficiency with Probiotic, Probiotics and Phytobiotics which attracted an enormous audience at the 2020 Animal Micorobiome And Nutritional Health Congress held March 3 […] See more

Following the signing of a Memorandum of Understanding/Cooperation Agreement (MOU) between the MIT startup Sunflower and Bioinnovo, Kerry Love, PhD and Laura Crowell, PhD visited Vetanco at its corporate headquarters. The purpose of the meeting was […] See more

Argentina’s Bioinnovo has updated its partnership with Spanish firm Algenex for the use of a molecule developed by the latter The renewed partnership provides Bioinnovo with the international rights to use Algenex’s APCH (antigen presenting […] See more

Last Tuesday Nov. 26rd a corporate meeting of the R&D international teams of Dr Bata, BV Science, Vetanco and Bioinnovo was held in Vetanco-Buenos Aires Head Office. The situation of ongoing projects and actual obstacles […] See more